GCCL Reaccredited for Regular Inspection of Medical Testing Institution International Standard 'ISO15189'

[Asia Economy Reporter Lee Gwan-joo] GCCL, a clinical trial specimen analysis institution, announced on the 18th that it has received re-accreditation for the regular inspection evaluation of the 'Medical Testing Institution International Standard ISO15189' from KOLAS, the Korea Laboratory Accreditation Scheme under the Ministry of Trade, Industry and Energy's National Institute of Technology and Standards.

ISO15189 is an international standard certification that guarantees that various clinical tests conducted in medical testing institutions meet technical requirements and reliability. KOLAS conducts regular inspections within 1 year after the initial accreditation and subsequently within 18 months to verify that accredited institutions continuously meet the recognition criteria.

This evaluation of GCCL was the first regular inspection conducted since the initial accreditation in March last year. After submitting re-accreditation documents in February, GCCL underwent document review and on-site evaluation for four months and was re-accredited. GCCL maintains the largest number of clinical chemistry test items in the same industry.

Lee Hee-joo, Head of Lab Operations at GCCL, said, "Through this ISO15189 regular inspection accreditation, we have secured reliability in providing specimen analysis services that meet global standards, and we plan to further accelerate our entry into the global market, including China, based on this foundation."

This content was produced with the assistance of AI translation services.